Sonavex, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-287/28/26 | New | $3,102,995 | $3,102,995 | Equity Only | 06b | SEC linkSEC |
| 2024-11-1911/19/24 | Amended | $15,000,004 | $12,700,004 | Equity Only | 06b | SEC linkSEC |
| 2022-02-022/2/22 | New | $2,300,000 | $2,300,000 | Equity Only | 06b | SEC linkSEC |
| 2019-11-0111/1/19 | New | $1,800,000 | $1,800,000 | Equity Only | 06b | SEC linkSEC |
| 2017-01-191/19/17 | Amended | $2,207,069 | $165,000 | Equity Only | 06b | SEC linkSEC |
| 2016-08-188/18/16 | New | $2,042,069 | $2,042,069 | Equity Only | 06b | SEC linkSEC |
| 2015-10-2010/20/15 | New | $320,192 | $320,192 | Equity Only | 06b | SEC linkSEC |
| 2015-06-296/29/15 | New | $70,000 | $70,000 | Debt Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Robert Hallenbeck | Director |
| Michael J. Hennessy, Jr. | Director |
| David Narrow | Director, Executive |
| Bill Niland | Director |
| William Niland | Director |
| Devin O'brien Coon | Director |
| Jerry Prince | Director |
| Evan Pritchard | Director |
| John Rappe | Executive |
| Alex Yevzlin | Executive |
Industry: Biotechnology (See others in industry)
Address:
2835 O'donnell Street Suite 200
Baltimore, MD, 21224
Phone: 443.862.2024
Baltimore, MD, 21224
Phone: 443.862.2024